276 related articles for article (PubMed ID: 9093426)
1. The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series.
Fleck SL; Robinson BL; Peters W; Thévin F; Boulard Y; Glénat C; Caillard V; Landau I
Ann Trop Med Parasitol; 1997 Jan; 91(1):25-32. PubMed ID: 9093426
[TBL] [Abstract][Full Text] [Related]
2. The chemotherapy of rodent malaria. LIV. Combinations of 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites.
Fleck SL; Robinson BL; Peters W
Ann Trop Med Parasitol; 1997 Jan; 91(1):33-9. PubMed ID: 9093427
[TBL] [Abstract][Full Text] [Related]
3. The chemotherapy of rodent malaria. L. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 3: Observations on 'Fenozan-50F', a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane.
Peters W; Robinson BL; Tovey G; Rossier JC; Jefford CW
Ann Trop Med Parasitol; 1993 Apr; 87(2):111-23. PubMed ID: 8561518
[TBL] [Abstract][Full Text] [Related]
4. The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials.
Peters W; Fleck SL; Robinson BL; Stewart LB; Jefford CW
Ann Trop Med Parasitol; 2002 Sep; 96(6):559-73. PubMed ID: 12396319
[TBL] [Abstract][Full Text] [Related]
5. The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1999 Jun; 93(4):325-9. PubMed ID: 10656034
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium vinckei petteri: identification of the stages sensitive to arteether.
Caillard V; Beauté-Lafitte A; Chabaud AG; Landau I
Exp Parasitol; 1992 Dec; 75(4):449-56. PubMed ID: 1493877
[TBL] [Abstract][Full Text] [Related]
7. The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo.
Peters W; Robinson BL; Rossier JC; Misra D; Jefford CW; Rossiter JC
Ann Trop Med Parasitol; 1993 Feb; 87(1):9-16. PubMed ID: 8346994
[TBL] [Abstract][Full Text] [Related]
8. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP
Int J Parasitol; 2017 Dec; 47(14):913-922. PubMed ID: 28864033
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1997 Mar; 91(2):141-5. PubMed ID: 9307655
[TBL] [Abstract][Full Text] [Related]
10. The chemotherapy of rodent malaria. LVIII. Drug combinations to impede the selection of drug resistance, Part. 2: The new generation--artemisinin or artesunate with long-acting blood schizontocides.
Peters W; Robinson BL
Ann Trop Med Parasitol; 2000 Jan; 94(1):23-35. PubMed ID: 10723521
[TBL] [Abstract][Full Text] [Related]
11. Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans) against the multidrug-resistant strain of Plasmodium yoelii nigeriensis (MDR) in vivo.
Tripathi R; Jefford CW; Dutta GP
Parasitology; 2006 Jul; 133(Pt 1):1-9. PubMed ID: 16764736
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model.
Janse CJ; Waters AP; Kos J; Lugt CB
Int J Parasitol; 1994 Jul; 24(4):589-94. PubMed ID: 8082988
[TBL] [Abstract][Full Text] [Related]
13. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605.
Peters W; Robinson BL; Milhous WK
Ann Trop Med Parasitol; 1993 Dec; 87(6):547-52. PubMed ID: 8122915
[TBL] [Abstract][Full Text] [Related]
14. Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission.
Mustfa K; Landau I; Chabaud AG; Chavatte JM; Chandenier J; Duong TH; Richard-Lenoble D
Sante; 2011; 21(3):133-42. PubMed ID: 22294247
[TBL] [Abstract][Full Text] [Related]
15. The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes.
Peters W; Li ZL; Robinson BL; Warhurst DC
Ann Trop Med Parasitol; 1986 Oct; 80(5):483-9. PubMed ID: 3307655
[TBL] [Abstract][Full Text] [Related]
16. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
Peters W; Stewart LB; Robinson BL
Ann Trop Med Parasitol; 2005 Jul; 99(5):457-72. PubMed ID: 16004705
[TBL] [Abstract][Full Text] [Related]
17. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
18. Convenient access both to highly antimalaria-active 10-arylaminoartemisinins, and to 10-alkyl ethers including artemether, arteether, and artelinate.
Haynes RK; Chan HW; Ho WY; Ko CK; Gerena L; Kyle DE; Peters W; Robinson BL
Chembiochem; 2005 Apr; 6(4):659-67. PubMed ID: 15812783
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-artemisinin combination therapy for malaria.
Nandakumar DN; Nagaraj VA; Vathsala PG; Rangarajan P; Padmanaban G
Antimicrob Agents Chemother; 2006 May; 50(5):1859-60. PubMed ID: 16641461
[TBL] [Abstract][Full Text] [Related]
20. Qinghaosu resistance in rodent malaria.
Chawira AN; Warhurst DC; Peters W
Trans R Soc Trop Med Hyg; 1986; 80(3):477-80. PubMed ID: 3541309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
